Home/Filings/4/0001567619-20-017108
4//SEC Filing

Miller Vincent A. 4

Accession 0001567619-20-017108

CIK 0001628171other

Filed

Sep 24, 8:00 PM ET

Accepted

Sep 25, 4:29 PM ET

Size

5.3 KB

Accession

0001567619-20-017108

Insider Transaction Report

Form 4
Period: 2020-09-23
Transactions
  • Sale

    Common Stock

    2020-09-23$34.02/sh500$17,01032,133 total
Footnotes (3)
  • [F1]Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.
  • [F2]The transaction was executed in multiple trades in prices ranging from $34.00 to $34.0650, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
  • [F3]Includes 1,808 Restricted Stock Units.

Documents

1 file

Issuer

Revolution Medicines, Inc.

CIK 0001628171

Entity typeother

Related Parties

1
  • filerCIK 0001584999

Filing Metadata

Form type
4
Filed
Sep 24, 8:00 PM ET
Accepted
Sep 25, 4:29 PM ET
Size
5.3 KB